Irungattukottai, Chennai - Oral Formulations (Generics)
Our modern oral formulations manufacturing facility at Irungattukottai (IKKT), near Chennai has modern infrastructure geared to offer high throughput. Coupled with world-class R&D labs, this formulations infrastructure is in the forefront of our successful entry into the advanced markets of US and Europe. With a vast site area, our oral formulations facility manufactures various types of dosage forms such as oral tablets and capsules in diverse dosage strengths and product categories.
The facility has been inspected and approved by leading regulatory agencies including the US FDA, UK MHRA, MCC (South Africa) and Danish Medicines Agency, based on specific filings. Several ANDAs (abbreviated new drug applications) have been filed from this complex with approvals and new launches underway.
The formulations facility also houses a modern R&D centre for pharmaceuticals research.
Alathur, Chennai - Oral Formulations (Emerging)
Oral non-cephalosporin formulations facility
Our oral non-cephalosporin formulations facility specialises in the manufacturing of nutraceutical products. The facility produces a range of dietary supplements for the advanced markets. Many other high-value products like anti-diabetics, cardio vascular drugs (CVS), anti-depressants and anti-epileptics are manufactured in this facility to cater to the emerging markets.
Built to GMP (good manufacturing practices) standards (WHO guidelines), this facility has state-of-the-art packaging machinery and a full-spectrum, dedicated quality control and microbiological services, adding distinctiveness to the manufacturing quality. Designed for optimal operating conditions and uni-directional flow of resources and materials, the facility has been approved by the Australian-TGA and is being offered for inspection by several other leading international regulatory agencies.
Oral cephalosporin formulations facility
Our oral cephalosporin formulations facility manufactures cephalosporin oral products dedicated to the domestic and emerging markets. The facility has the capability to manufacture different dosage forms like tablets, capsules, dry syrups and liquid orals. The facility conforms to cGMP standards and is approved by the WHO.